XML 37 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:    
Net income (loss) $ 12,643 $ (7,178)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Amortization of bond premium or discount 1,350 1,715
Net realized (gain) loss on sale of investments (435) 754
Unrealized (gain) loss on trading securities 651 4,022
Equity-based compensation expense 600 301
Changes in assets and liabilities:    
Accrued investment income 379 249
Other assets 472 349
Change in cash equivalents held in trust 22,649 4,716
Change in restricted cash 71 25,054
Losses and loss adjustment reserves (22,148) (24,954)
Losses payable (1,875) 141
Unearned premiums (238) 1,281
Accrued ceding commission expense (54) (32)
Accrued interest on notes payable (814) (369)
Loss contract fair market value reserve (30,287) (987)
Other liabilities (710) (63)
Total adjustments (30,389) 12,177
Net cash (used in) provided by operating activities: (17,746) 4,999
Cash flows from investing activities:    
Purchase of investments (431,113) (297,475)
Proceeds from sales and maturities of investments 511,332 318,153
Net cash provided by (used in) investing activities: 80,219 20,678
Cash flows from financing activities:    
Proceeds from issuance of preferred stock and warrants to purchase common stock 22,572  
Fees incurred relating to preferred stock and warrant issuance (3,348)  
Deferred offering costs (12,166)  
Notes payable – principal repayments (78,890) (36,294)
Notes payable – principal issued 3,718 2,203
Net cash provided by (used in) financing activities: (68,114) (34,091)
Increase (decrease) in cash and cash equivalents (5,641) (8,414)
Cash and cash equivalents, beginning of period 11,986 16,761
Cash and cash equivalents, end of period 6,345 8,347
Cash paid during the period:    
Interest 5,094 9,707
Supplementary disclosure of non-cash investing and financing activities:    
Notes payable issued in lieu of cash interest payments 3,718 2,203
Preferred deemed dividend recorded due to beneficial conversion feature $ 9,455